HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Tsuruo Selected Research

Therapeutics

5/2009De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy.
1/2009Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
11/2001[Comparison of management of advanced cancer in various organs].
7/2001A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
5/2001[Platinum compounds in cancer therapy--past, present, and future].
1/2001Activation of caspase protease during apoptosis in ovarian cancer cells.
10/2000[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Tsuruo Research Topics

Disease

29Neoplasms (Cancer)
05/2009 - 01/2000
9Neoplasm Metastasis (Metastasis)
12/2002 - 01/2000
5Carcinoma (Carcinomatosis)
12/2002 - 03/2000
4Ovarian Neoplasms (Ovarian Cancer)
07/2008 - 05/2000
4Colonic Neoplasms (Colon Cancer)
11/2000 - 05/2000
4Colorectal Neoplasms (Colorectal Cancer)
08/2000 - 01/2000
3Myeloid Leukemia (Leukemia, Myelocytic)
11/2001 - 11/2000
3Leukemia
08/2001 - 05/2000
3Melanoma (Melanoma, Malignant)
08/2000 - 01/2000
2Glioma (Gliomas)
01/2009 - 12/2000
2Stomach Neoplasms (Stomach Cancer)
12/2002 - 05/2000
2Hypoxia (Hypoxemia)
09/2001 - 05/2000
2Lung Neoplasms (Lung Cancer)
08/2001 - 09/2000
2Breast Neoplasms (Breast Cancer)
04/2000 - 01/2000
1Acidosis
01/2009
1Leukemia P388
11/2001
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2001
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2001
1Carcinogenesis
08/2000
1Starvation
05/2000
1Retinoblastoma (Glioblastoma, Retinal)
04/2000

Drug/Important Bio-Agent (IBA)

6Doxorubicin (Adriamycin)FDA LinkGeneric
07/2008 - 05/2000
4DNA (Deoxyribonucleic Acid)IBA
03/2006 - 04/2000
4Messenger RNA (mRNA)IBA
12/2002 - 03/2000
3EnzymesIBA
05/2009 - 05/2000
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2001 - 11/2000
3CaspasesIBA
09/2001 - 01/2001
3Etoposide (VP 16)FDA LinkGeneric
08/2001 - 05/2000
2Small Interfering RNA (siRNA)IBA
01/2009 - 07/2008
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2006 - 06/2000
2Monoclonal AntibodiesIBA
11/2001 - 01/2000
2Immunosuppressive Agents (Immunosuppressants)IBA
11/2001 - 01/2000
2Vincristine (Oncovin)FDA LinkGeneric
11/2001 - 11/2000
2Antineoplastic Agents (Antineoplastics)IBA
08/2001 - 05/2000
2Lactoylglutathione LyaseIBA
08/2001 - 05/2000
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2000 - 01/2000
2Type I DNA Topoisomerases (Topoisomerase I)IBA
05/2000 - 05/2000
2Proteins (Proteins, Gene)FDA Link
04/2000 - 03/2000
2Fluorouracil (Carac)FDA LinkGeneric
04/2000 - 03/2000
2ParaffinIBA
01/2000 - 01/2000
2Formaldehyde (Formol)FDA Link
01/2000 - 01/2000
1LipidsIBA
05/2009
1Fatty Acids (Saturated Fatty Acids)IBA
05/2009
1MidkineIBA
01/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2009
1Heparin (Liquaemin)FDA LinkGeneric
01/2009
1acyl CoA synthetase 5IBA
01/2009
1Superoxides (Superoxide)IBA
07/2008
1Paclitaxel (Taxol)FDA LinkGeneric
07/2008
1Free RadicalsIBA
07/2008
1telomestatinIBA
03/2006
1Telomeric Repeat Binding Protein 2IBA
03/2006
1Carcinoembryonic AntigenIBA
12/2002
1Liposomes (Liposome)IBA
11/2001
1Pain-FreeIBA
11/2001
1SNF 4435CIBA
11/2001
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
09/2001
1Laminin (Merosin)IBA
09/2001
1Topoisomerase InhibitorsIBA
09/2001
1p38 Mitogen-Activated Protein KinasesIBA
08/2001
1Phosphotransferases (Kinase)IBA
08/2001
1Protein Kinases (Protein Kinase)IBA
08/2001
1dofequidar (MS 209)IBA
07/2001
1quinolineIBA
07/2001
1Therapeutic UsesIBA
07/2001
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2001
1A-Form DNA (A-DNA)IBA
05/2001
1Platinum Compounds (Compounds, Platinum)IBA
05/2001
1Peptide Hydrolases (Proteases)FDA Link
01/2001
1ethyl acetateIBA
11/2000
1src-Family KinasesIBA
11/2000
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2000
1Topotecan (Hycamtin)FDA LinkGeneric
09/2000
1Topoisomerase I InhibitorsIBA
09/2000
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2000
1CollagenIBA
08/2000
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2000
1Transcription Factors (Transcription Factor)IBA
08/2000
1Antisense OligonucleotidesIBA
08/2000
1Taxoids (Taxanes)IBA
08/2000
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2000
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2000
1taxuspine CIBA
06/2000
1Complementary DNA (cDNA)IBA
05/2000
1lactacystinIBA
05/2000
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2000
1Glucose (Dextrose)FDA LinkGeneric
05/2000
1CamptothecinIBA
05/2000
1Proteasome Endopeptidase Complex (Proteasome)IBA
05/2000
1Proteasome InhibitorsIBA
05/2000
1trioctyl phosphine oxide (TOPO)IBA
05/2000
1Type II DNA Topoisomerases (Topoisomerase II)IBA
05/2000
1Thymidylate SynthaseIBA
04/2000
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
03/2000
1Estrogens (Estrogen)FDA Link
01/2000

Therapy/Procedure

10Drug Therapy (Chemotherapy)
07/2008 - 05/2000
7Therapeutics
05/2009 - 10/2000
3Intravenous Injections
09/2001 - 04/2000
1Gastrectomy
12/2002
1Adjuvant Chemotherapy
04/2000